Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abdominal aBscess Catheter Sclerotherapy (ABCS)
NCT06906029Phase 2Active, not recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of povidone-iodine, ethanol in abdominal abscess, sponsored by University of Alabama at Birmingham. Started Dec 2025; status: active, not recruiting.
02
Drugs
povidone-iodineethanol
03
Conditions
abdominal abscess
Beyond the preview
Go deeper on NCT06906029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06906029.